This is a complete change of control to an individual with no public-company CEO experience and no disclosed plan for the company. The new controller's background in industrial engineering in Venezuela suggests a potential pivot away from the current management consulting business. Monitor for a new business direction, potential reverse merger, or asset sale. The lack of an employment agreement and the low acquisition cost ($0.0033/share) imply the new controller may view the company primarily as a public shell.
Price Chart
Executive Summary
Controlling shareholder Stephen Ken Adair sold his entire stake (88M common shares + 300K Series A preferred shares) to Angel Javier Perez Jimenez for a total of $291,390, and simultaneously resigned from all officer and director positions. Perez Jimenez, a 32-year-old industrial engineer from Venezuela with no prior CEO experience, was appointed as sole director and all C-suite roles. This is a complete change of control with no employment agreement or compensatory arrangement for the new controller, creating significant uncertainty about the company's strategic direction and operational continuity.
Key Facts
- Stephen Ken Adair sold 88,000,000 common shares and 300,000 Series A preferred shares to Angel Javier Perez Jimenez for a total of $291,390 ($0.0033/share).
- Adair resigned from all positions (President, CEO, CFO, Treasurer, Secretary, sole Director) effective August 10, 2026.
- Perez Jimenez, age 32, was appointed as President, CEO, CFO, Treasurer, Secretary, and sole Director effective August 10, 2026.
- Perez Jimenez's background is as a Process & Operations Engineer in Caracas, Venezuela; no employment agreement or compensatory arrangement was entered into.
- The transfer was completed and reflected on the transfer agent's records on August 24, 2026.
- No portion of the purchase price was payable to the company.
Financial Impact
Total consideration of $291,390 for control of the company; no proceeds to the company.
Risk Factors
- New controller has no public-company CEO experience and no disclosed strategic plan.
- Potential for a reverse merger or business combination that could dilute or extinguish existing shareholder value.
- Lack of employment agreement or compensatory arrangement raises questions about commitment and governance.
- Company is a micro-cap OTC stock with a history of name changes (Amersin Life Sciences, Hubei Pharmaceutical, Pan Asia Communications), indicating a pattern of shell-like activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-007139 |
| Document: invech_ex1002.htm | 0001683168-26-007139 |
| Document: invech_ex1001.htm | 0001683168-26-007139 |
| Document: 0001683168-26-007139-index-headers.html | 0001683168-26-007139 |
| Document: 0001683168-26-007139-index.html | 0001683168-26-007139 |
| Document: 0001683168-26-007139.txt | 0001683168-26-007139 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 6w ago | 8-K | $0.0300 | awaiting T+60 | — | — |
Aug 3, 2026 12w ago | 8-K | $0.0310 | awaiting T+60 | — | — |
Jun 4, 2026 20w ago | 8-K | $0.0448 $0.0290 | ▼ −35.27% | ▼ −37.15% | — |
Apr 23, 2026 26w ago | 8-K | $0.0584 $0.0370 | ▼ −36.65% | ▼ −41.73% | — |
Apr 13, 2026 28w ago | EFFECT | $0.0680 $0.0341 | ▲ +49.82% | ▲ +58.74% | — |
Mar 5, 2026 33w ago | 8-K | $0.1400 $0.0584 | ▲ +58.29% | ▲ +69.59% | — |
Mar 4, 2026 33w ago | 8-K | $0.1044 $0.0522 | ▲ +50.00% | ▲ +60.09% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers